TaiCoo Biologics Q4 2025 Financials

TaiCoo Biologics Inc. reported an operating revenue of NT.005 billion and a net loss of NT61 million for Q4 2025, with basic EPS at -NT.51.
生技醫療業NQ 53/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: December 1, 2025 at 09:00
  • 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
  • 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 20m after Collected)
Company Code: 6589. Company Name: TaiCoo Biologics Inc. Industry: Biotechnology and Medical Industry. Year/Quarter: 2025 Q4. Basic Earnings Per Share: -NT.51. Operating Revenue: NT.005 billion. Net Income After Tax: -NT61 million.

Back to Newsroom (6)